Even though this mouse model represents ASM/mast cell leukemia when fully manifested, the accumulation of transformed mast cells is progressive and the associated changes in circulating ROS, DJ-1, and IL-6 at the initial stages parallel the changes observed in ISM. The gene discussed is IL6; the disease is mast cell leukemia.